ASPR/BARDA Procurement and Late-stage Development of Smallpox Antiviral Drugs

The purpose of this Other Than Small Business Sources Sought Notice is to use responses for planning potential future acquisitions. BARDA seeks pertinent marketplace data on availabilities and capabilities for late-stage development of a smallpox antiviral MCM candidate for stockpiling in the Strategic National Stockpile (SNS). BARDA intends to fund the procurement and development of both a nonparenteral and parental formulation of a smallpox antiviral candidate to address preparedness requirements and the needs of special populations. At a minimum, the drug should have established efficacy parameters as determined by the FDA in at least two appropriate orthopoxvirus animal model (e.g. Monkeypox, Rabbitpox).

Information is being sought on availabilities, capabilities, and other pertinent marketplace data to strengthen BARDA's understanding of the current and future marketplace enhance its ability to obtain quality services economically, and to efficiently and lawfully establish potential vendor source files and listings. No contracts will be awarded under this notice. Please see the attached Sources Sought Notice.